EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis ...
A new analysis of diagnostic company Immunovia's Pancreasure has been published in the peer-reviewed Journal of Clinical Medicine. The analysis covers people at elevated hereditary or familial risk of ...
Landmark Nationwide Trial Shows Genome Sequencing Beats Standard Testing for Developmental Disorders
A nationwide Belgian randomized trial of 567 patients found that genome sequencing diagnosed 39.8 percent of developmental disorder cases, significantly outperforming the standard combination of exome ...
A routine blood draw may one day help catch one of the world’s most common kidney cancers before it spreads, according to a study published in Epigenetics Communications. Researchers in Japan report t ...
Early genetic testing can help identify the causes of unexplained developmental delays in children, enabling timely treatment ...
Multiomic analyses identify RORC-expressing DCs enriched in patient-derived malignant ascites and enable functional ...
EpiSign Inc. today announced the launch of EpiSign METRIC 5-base, extending its comprehensive and automated episignature analysis framework beyond methylation microarrays to sequencing-derived DNA ...
Growth strategies focus on affordable D2C kits, retail expansion, NGS innovation, digital integration and privacy safeguards to capture personalized and preventive care demandDublin, Sept. (GLOBE ...
The team examined whether widely studied anti-aging strategies produce consistent changes in biological age. Unlike ...
QYResearch has recently released the industry report, "2026 Global SNP Microarray Testing and Analysis Market Research Report". This report analyzes the technical platforms, market size, competitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results